Q-PHARM DENIES TRIAL ALLEGATIONS

Written on the 16 April 2010

Q-PHARM DENIES TRIAL ALLEGATIONS

A HERSTON-BASED contract research company has denied an association with clinical trial consultancy Rewards for Research, following controversy surrounding alleged financial incentives for volunteers.

The Sunday Telegraph reported that Rewards for Research advertises on Facebook to attract young people as human guinea pigs, listing Q-Pharm as a client.

Under the National Health and Medical Research Council’s (NHMRC) ethical conduct rules, payments to volunteers should not be disproportionate to time involved or encourage participants to take risks.

It is alleged that the South Brisbane-based Rewards for Research had advertised for clinical trials worth up to $2000 for participants in some cases.

But Q-Pharm CEO Terry Hurst told brisbanebusinessnews.com.au that the consultancy was only a client for one trial between 2006 and 2007 and that his company had since severed ties with the organisation.

“They are not a client of ours and they’re not a company we’ve chosen to be associated with,” says Hurst.

“Volunteers, particularly in early phase trials, are reimbursed for their out-of-pocket expenses, as well as for their time and inconvenience. Reimbursements are generally less than the minimum wage.”

Hurst declined to comment on Q-Pharm’s current volunteer recruitment policies, but affirms they are ‘ethically approved’ and follow NHMRC guidelines.


Latest News

SLATER AND GORDON TAKES SPOTLESS TO COURT

SPOTLESS Group (ASX: SPO) has been hit by a class action launched by Slater and Gordon (ASX: SGH) in the Federal C...

ANSELL'S SHARE PRICE SWELLS AFTER SALE OF CONDOM BUSINESS

IT'S one of Australia's most successful and enduring manufacturing success stories and the Ansell condom busi...

TOPSHOP GOES INTO ADMINISTRATION AMID VOLATILE RETAIL MARKET

TOPSHOP has become the latest in a string of retailers blasted by the volatile retail market, as the iconic fashio...

SIGMA'S SHARE PRICE TAKES A BATTERING AS IT LAUNCHES LEGAL ACTION OVER SUPPLY DEAL

SIGMA Healthcare (ASX: SIG) has taken the MyChemist and Chemist Warehouse chains to court to demand they continue to ...

Related News

SLATER AND GORDON TAKES SPOTLESS TO COURT

SPOTLESS Group (ASX: SPO) has been hit by a class action launched by Slater and Gordon (ASX: SGH) in the Federal C...

TOPSHOP GOES INTO ADMINISTRATION AMID VOLATILE RETAIL MARKET

TOPSHOP has become the latest in a string of retailers blasted by the volatile retail market, as the iconic fashio...

SIGMA'S SHARE PRICE TAKES A BATTERING AS IT LAUNCHES LEGAL ACTION OVER SUPPLY DEAL

SIGMA Healthcare (ASX: SIG) has taken the MyChemist and Chemist Warehouse chains to court to demand they continue to ...

REGIONAL BANKS HIT OUT AT RATING CUT AND WARN BIG FOUR WILL BENEFIT

REGIONAL banks have hit out at a downgrade on their credit ratings, warning that it will increase their wholesale fun...

BOOK YOUR FUNCTION SPACE HERE

 

 

 

Contact us

Email News Update Sign Up Contact Details
Subscriptions

PO Box 2087
Brisbane QLD 4001

LoginTell a FriendSign Up to Newsletter